Activity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorSubbiah, V.
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorBesse, B.
dc.contributor.authorMoreno, V.
dc.contributor.authorZaman, K.
dc.contributor.authorSala Gonzalez, M. A.
dc.contributor.authorLopez-Vilarino, J. A.
dc.contributor.authorFernandez, C. M.
dc.contributor.authorKahatt, C.
dc.contributor.authorSiguero, M.
dc.contributor.authorZeaiter, A.
dc.contributor.authorLopez Lopez, R.
dc.contributor.authorPonce Aix, S.
dc.contributor.authorBoni, V.
dc.contributor.authorArrondeau, J.
dc.contributor.authorDelord, J-P.
dc.contributor.authorMartinez-Aguillo, M.
dc.contributor.authorDe Nicola, L. Wannesson
dc.contributor.authorAnton Torres, A.
dc.contributor.authorTrigo Perez, J. M.
dc.contributor.authoraffiliation[Subbiah, V.] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
dc.contributor.authoraffiliation[Paz-Ares, L.] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Ponce Aix, S.] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Besse, B.] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
dc.contributor.authoraffiliation[Moreno, V.] Univ Hosp Fdn Jimenez Diaz, START Madrid FJD, Clin Res Phase Trials Unit 1, Madrid, Spain
dc.contributor.authoraffiliation[Zaman, K.] CHUV Ctr Hosp Univ Vaudois, Dept Oncol, Lausanne, Switzerland
dc.contributor.authoraffiliation[Sala Gonzalez, M. A.] Hosp Basurto, Oncol, Bilbao, Spain
dc.contributor.authoraffiliation[Lopez-Vilarino, J. A.] Pharma Mar SA, Clin Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Fernandez, C. M.] Pharma Mar SA, Clin Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Kahatt, C.] Pharma Mar SA, Clin Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Siguero, M.] Pharma Mar SA, Clin Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Zeaiter, A.] Pharma Mar SA, Clin Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Lopez Lopez, R.] Hosp Clin Univ Santiago de Compostela, Oncol, Santiago De Compostela, La Coruna, Spain
dc.contributor.authoraffiliation[Boni, V.] Hosp Madrid Norte San Chinarro, Ctr Integral Oncol Clara Campal, Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Arrondeau, J.] Hop Cochin, Oncol, Paris, France
dc.contributor.authoraffiliation[Delord, J-P.] Inst Claudius Regaud, Oncol, Haute Garonne, France
dc.contributor.authoraffiliation[Martinez-Aguillo, M.] Complejo Hosp Navarra, Royal Navarre Hosp, Med Oncol, Pamplona, Spain
dc.contributor.authoraffiliation[De Nicola, L. Wannesson] IOSI Osped Reg Bellinzona & Valli, Oncol, Bellinzona, Switzerland
dc.contributor.authoraffiliation[Anton Torres, A.] Hosp Miguel Servet, Dept Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Trigo Perez, J. M.] Hosp Univ Virgen de la Victoria, Dept Med Oncol, Malaga, Spain
dc.date.accessioned2025-01-07T15:04:01Z
dc.date.available2025-01-07T15:04:01Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1545
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420415418/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26854
dc.identifier.wosID573469102368
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.page.numberS1034-S1035
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleActivity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía